Biopharmaceuticals' Immunogenicity
Received Date: Apr 01, 2024 / Accepted Date: Apr 30, 2024 / Published Date: Apr 30, 2024
Abstract
Biopharmaceuticals have revolutionized healthcare by offering targeted and efficacious treatment options for a myriad of diseases. However, concerns about their high costs and affordability have sparked discussions about their cost-effectiveness. This abstract provides a succinct overview of the complex interplay between innovation and affordability in the realm of biopharmaceuticals, examining the factors influencing pricing, economic impact, and strategies for achieving sustainable healthcare delivery.
Citation: Laurie C (2024) Biopharmaceuticals' Immunogenicity. Clin PharmacolBiopharm, 13: 444.
Copyright: © 2024 Laurie C. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
